Investigates the synthesis and properties of FA@Fe3O4 nanoparticles, suggesting potential for hyperthermia therapy.
A magnetic composite FA@Fe3O4 is formed by coupling magnetic iron oxide (Fe3O4) with folic acid (FA) through a facile hydrothermal synthesis process. The morphology, particle size, elemental composition, and magnetocaloric properties have been characterized by means of transmission electron microscopy (TEM), scanning electron microscopy (SEM), X-ray diffractometry (XRD), vibrating sample magnetometry (VSM), X-ray photoelectron spectrometry (XPS), and Fourier transform infrared spectroscopy (FTIR). Microscopic images showed that the Fe3O4 NPs were spherical, and their average size could be tuned from 13 ± 4 nm to 230 ± 4 nm by varying the OAm/EG ratio. According to the FTIR and XPS results, FA was chemically bonded to the amide bond on the surface of Fe3O4. The particles display ferromagnetic characteristics. Notably, FA@Fe3O4 retains favorable magnetic properties after FA modification, showing superparamagnetic behavior with a saturation magnetization of 64–69 emu/g. Although this value is somewhat lower than that of unmodified Fe3O4 (71.0 emu/g), no significant degradation in the magnetic performance was observed. According to the results of the MTT cytotoxicity evaluation experiment, FA@Fe3O4 exhibits low cytotoxicity (cell viability >80% at 0.25 mg/mL). What is more, FA@Fe3O4 magnetic fluid has good stability and superparamagnetic properties and is expected to mediate targeted hyperthermia therapy for malignant tumors.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: